Aeglea BioTherapeutics
Why Robinhood?
You can watch AGLE and buy or sell other stocks, ETFs, and their options commission-free!About AGLE
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency.
AGLE Key Statistics
Stock Snapshot
The current Aeglea BioTherapeutics(AGLE) stock price is $11.75, with a market capitalization of 918.73M. The stock trades at a price-to-earnings (P/E) ratio of -20.00.
On 2026-03-11, Aeglea BioTherapeutics(AGLE) stock opened at —, reached a high of —, and a low of —.
The Aeglea BioTherapeutics(AGLE)'s current trading volume is 0, compared to an average daily volume of 688.85K.
In the last year, Aeglea BioTherapeutics(AGLE) shares hit a 52-week high of $45.76 and a 52-week low of $10.91.
In the last year, Aeglea BioTherapeutics(AGLE) shares hit a 52-week high of $45.76 and a 52-week low of $10.91.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.